These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25151916)

  • 1. Are PTSD treatment choices and treatment beliefs related to depression symptoms and depression-relevant treatment rationales?
    Rytwinski NK; Rosoff CB; Feeny NC; Zoellner LA
    Behav Res Ther; 2014 Oct; 61():96-104. PubMed ID: 25151916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do changes in trauma-related beliefs predict PTSD symptom improvement in prolonged exposure and sertraline?
    Cooper AA; Zoellner LA; Roy-Byrne P; Mavissakalian MR; Feeny NC
    J Consult Clin Psychol; 2017 Sep; 85(9):873-882. PubMed ID: 28504542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doubly Randomized Preference Trial of Prolonged Exposure Versus Sertraline for Treatment of PTSD.
    Zoellner LA; Roy-Byrne PP; Mavissakalian M; Feeny NC
    Am J Psychiatry; 2019 Apr; 176(4):287-296. PubMed ID: 30336702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of positive patient testimonials on PTSD treatment choice.
    Pruitt LD; Zoellner LA; Feeny NC; Caldwell D; Hanson R
    Behav Res Ther; 2012 Dec; 50(12):805-13. PubMed ID: 23103234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual symptoms of PTSD following Sertraline plus enhanced medication management, Sertraline plus PE, and PE plus placebo.
    Tripp JC; Norman SB; Kim HM; Venners MR; Martis B; Simon NM; Stein MB; Allard CB; Rauch SAM;
    Psychiatry Res; 2020 Sep; 291():113279. PubMed ID: 32763541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "How will it help me?" Reasons underlying treatment preferences between sertraline and prolonged exposure in posttraumatic stress disorder.
    Chen JA; Keller SM; Zoellner LA; Feeny NC
    J Nerv Ment Dis; 2013 Aug; 201(8):691-7. PubMed ID: 23896851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining PTSD treatment choice among individuals with subthreshold PTSD.
    Bergman HE; Kline AC; Feeny NC; Zoellner LA
    Behav Res Ther; 2015 Oct; 73():33-41. PubMed ID: 26246029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Prolonged Exposure Therapy, Sertraline Hydrochloride, and Their Combination Among Combat Veterans With Posttraumatic Stress Disorder: A Randomized Clinical Trial.
    Rauch SAM; Kim HM; Powell C; Tuerk PW; Simon NM; Acierno R; Allard CB; Norman SB; Venners MR; Rothbaum BO; Stein MB; Porter K; Martis B; King AP; Liberzon I; Phan KL; Hoge CW
    JAMA Psychiatry; 2019 Feb; 76(2):117-126. PubMed ID: 30516797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating "types" of treatment dropout: Nonstarters in an RCT of prolonged exposure versus sertraline.
    Kline AC; Baier AL; Klein AB; Feeny NC; Zoellner LA
    Behav Res Ther; 2020 Dec; 135():103750. PubMed ID: 33035741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What you believe is what you want: modeling PTSD-related treatment preferences for sertraline or prolonged exposure.
    Zoellner LA; Feeny NC; Bittinger JN
    J Behav Ther Exp Psychiatry; 2009 Sep; 40(3):455-67. PubMed ID: 19577224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Response to Prolonged Exposure, Sertraline, and Their Combination for the Treatment of Military PTSD.
    Rauch SAM; Kim HM; Lederman S; Sullivan G; Acierno R; Tuerk PW; Simon NM; Venners MR; Norman SB; Allard CB; Porter KE; Martis B; Bui E; Baker AW;
    J Clin Psychiatry; 2021 Jun; 82(4):. PubMed ID: 34133087
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of prolonged exposure and sertraline on emotion regulation in individuals with posttraumatic stress disorder.
    Jerud AB; Pruitt LD; Zoellner LA; Feeny NC
    Behav Res Ther; 2016 Feb; 77():62-7. PubMed ID: 26723004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression sudden gains and transient depression spikes during treatment for PTSD.
    Keller SM; Feeny NC; Zoellner LA
    J Consult Clin Psychol; 2014 Feb; 82(1):102-11. PubMed ID: 24364793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden gains in prolonged exposure and sertraline for chronic PTSD.
    Jun JJ; Zoellner LA; Feeny NC
    Depress Anxiety; 2013 Jul; 30(7):607-13. PubMed ID: 23633445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reductions in guilt cognitions following prolonged exposure and/or sertraline predict subsequent improvements in PTSD and depression.
    Allard CB; Norman SB; Straus E; Kim HM; Stein MB; Simon NM; Rauch SAM;
    J Behav Ther Exp Psychiatry; 2021 Dec; 73():101666. PubMed ID: 34147766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaginal exposure exacerbation revisited: Deconstructing patient characteristics associated with worse reactions to the initiation of imaginal exposure in PTSD.
    Walker RSW; Marks EH; Jaeger J; Duax JM; Feeny NC; Zoellner LA
    Behav Res Ther; 2020 Dec; 135():103747. PubMed ID: 33049550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder.
    Rothbaum BO; Cahill SP; Foa EB; Davidson JR; Compton J; Connor KM; Astin MC; Hahn CG
    J Trauma Stress; 2006 Oct; 19(5):625-38. PubMed ID: 17075912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What would you choose? Sertraline or prolonged exposure in community and PTSD treatment seeking women.
    Feeny NC; Zoellner LA; Mavissakalian MR; Roy-Byrne PP
    Depress Anxiety; 2009; 26(8):724-31. PubMed ID: 19544313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Providing a treatment rationale for PTSD: does what we say matter?
    Feeny NC; Zoellner LA; Kahana SY
    Behav Res Ther; 2009 Sep; 47(9):752-60. PubMed ID: 19616197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of prolonged exposure therapy versus pharmacotherapy and treatment choice in posttraumatic stress disorder (the Optimizing PTSD Treatment Trial): a doubly randomized preference trial.
    Le QA; Doctor JN; Zoellner LA; Feeny NC
    J Clin Psychiatry; 2014 Mar; 75(3):222-30. PubMed ID: 24717377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.